Phase 3 Acute Myocardial Infarction Clinical Trials
6 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–6 of 6 trials
Recruiting
Phase 3
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With a Heart Attack
Cardiovascular RiskAcute Myocardial Infarction (AMI)
Novo Nordisk A/S10,000 enrolled970 locationsNCT06118281
Recruiting
Phase 3
Effects of Ziltivekimab on Coronary Atherosclerotic Burden in Patients With Acute Myocardial Infarction
Coronary Artery DiseaseAcute Myocardial Infarction (AMI)Coronary Atherosclerosis of Native Coronary Artery
ECRI bv332 enrolled1 locationNCT07276282
Recruiting
Phase 3
Effect of Glp-1 and Antidiabetic sgLT2 Agents for myoCardial infarcTion and Ultrasensitive Inflammatory Surveillance (GALACTUS Trial)
Acute Myocardial Infarction With ST Elevation
Instituto Mexicano del Seguro Social44 enrolled1 locationNCT07295223
Recruiting
Phase 3
Apixaban Prophylaxis for Prevention of Left Ventricular Thrombus Following Anterior Myocardial Infarction
left ventricular thrombusAcute Myocardial Infarction of Anterior WallProphylaxis
National Institute of Cardiovascular Diseases, Pakistan472 enrolled1 locationNCT06742567
Recruiting
Phase 3
Therapeutic Use of Angiopoietin-Primed Autologous Peripheral Blood Stem Cell in Myocardial Infarction
Acute Myocardial Infarction
Seoul National Hospital30 enrolled1 locationNCT06364150
Recruiting
Phase 3
Metformin and Prevention of Cardiovascular Events in Patients With Acute Myocardial Infarction and Prediabetes (MIMET)
PrediabetesAcute Myocardial InfarctionST Elevation Myocardial Infarction+1 more
Karolinska Institutet5,160 enrolled1 locationNCT05182970